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OBJECTIVES: Satisfaction with a medication can be an important driver of 
adherence; satisfaction also can be related to both medication administration 
and effectiveness. Our objective is to explore the association between medication 
adherence and satisfaction and the administration characteristics of respiratory 
medications – e.g., inhaled, oral, combinations - used for chronic obstructive 
pulmonary disease (COPD.) METHODS: Data were obtained from the 2012 U.S. 
National Health and Wellness Survey (NHWS). The NHWS is an annual Internet-
based survey, using stratified random sampling to ensure demographic 
representativeness of the adult U.S. population. Respondents reporting diagnosis 
with COPD, emphysema, and/or chronic bronchitis and taking an inhaled or oral 
prescription medication for their condition were included. Treatment groups 
were compared on demographics, treatment patterns, satisfaction and 
adherence (using the Morisky Medication Adherence Scale [MMAS]-8), using Chi-
square and ANOVA tests as appropriate. RESULTS: The 1,979 respondents were 
grouped as follows: 1.3% on a pill (leukotriene modifier), 18% long-acting 
bronchodilator inhaler (LABD) only, 20.4% on short-acting bronchodilator inhaler 
(SABD) only, 0.8% on pill combined with another non-SABD inhaler, 0.9% on 
pill+SABD, 6.1% inhaler combination (non-SABD), 27.9% inhaler combination 
with SABD, 0.9% on triple therapy (non-SABD) and 23.8% on triple therapy that 
includes SABD. Patients on pill only (n=25) medication were younger, reported 
lower disease severity and were less frequently current or former smokers 
versus other treatment groups (all p<0.05). Among pill-only patients, 60% were 
very/extremely satisfied with their treatment. Pill-only patients were 
significantly more adherent to their medication, compared with pill and inhaler 
combination and triple therapy (excluding SABD) groups, all p<0.05. Mean 
satisfaction and adherence scores were correlated at r=-0.131, p<0.0001, 
indicating that higher satisfaction is associated with better adherence to 
treatment. CONCLUSIONS: Oral medications have the potential to improve 
adherence and satisfaction in COPD treatment, but further research with larger 
samples is needed.  
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OBJECTIVES: Varenicline and bupropion are commonly recommended 
pharmacotherapies for smoking cessation. Post marketing reports suggest that 
bupropion and varenicline are associated with an increased incidence of 
psychiatric disturbances. However, pre-existing psychiatric conditions and lack 
of cigarettes (nicotine) confound the association between smoking cessation 
agents (SCA) and psychiatric disturbances. The aim of the study was to 
determine the impact of SCA on the mental health status. METHODS: Data were 
from the 2006-2010 Medical Expenditure Panel Survey. Adults with new episodes 
of varenicline or bupropion, defined as current use of one of these agents 
without prior use of any SCA agents in the previous round, were identified. The 
main outcome was the mental component summary (MCS) scores derived from 
the mental health component of SF-12v2. The MCS scores of SGA agent users 
were compared to that of current smokers and adults who quit smoking without 
any SCA use. Linear regression was used to adjust for sociodemographic 
characteristics, pre-existing psychiatric conditions, and medical comorbidities. 
RESULTS: There were 117 new episodes of varenicline use, 426 new episodes of 
bupropion use, 1138 subjects who quit smoking without any SCA and 9178 
current smokers. Compared to current smokers, varenicline use was associated 
with a statistically as well as clinically insignificant change in the MCS score 
(0.20) [p>0.05] while bupropion use was associated with a significant decrease in 
the MCS score (-4.18) [p<0.01]. Subjects who quit smoking with any SCA use were 
associated with a clinically insignificant increase in the MCS score (1.39) [p<0.01]. 
The presence of pre-existing psychiatric conditions was associated with a 
significant decrease in the MCS score [-4.33] (p<0.01). CONCLUSIONS: Varenicline 
is associated with an insignificant change in mental health status, compared 
with current smokers. The study supports the use of varenicline as first line 
therapy for smoking cessation.  
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OBJECTIVES: Poor asthma control is associated with deleterious clinical  
and economic outcomes. This research examined the association between 
asthma control and health-related quality of life (HRQL). METHODS: The 
Observational Study of Asthma Control and Outcomes (OSACO) was a 
prospective survey of asthma patients in Kaiser Colorado in 2011-2012. Patients 
were mailed a survey three times in one year. The survey included the Asthma 
Control Questionnaire (ACQ-6), mini-Asthma Quality of Life Questionnaire 
(AQLQ), EQ-5D and questions on asthma exacerbations and adherence. A subset 
received spirometry testing and completed the ACQ-7 at National Jewish Health. 
Regression analyses examined the impact of asthma control (ACQ) on EQ-5D, 
mini-AQLQ and VAS scores controlling for age, gender, family income level, race, 
educational attainment and ethnicity. The functional relationship between 
asthma control and each outcome was estimated. Different cut-points of the 
ACQ were explored (above-below .75, 1.0, 1.5; categories 0-1, 1-2, etc.; 0-0.75, 0.75-
1.5, etc.). RESULTS: There were 2,683 respondents to the first survey of whom 
596 completed spirometry. The relationship between ACQ scores and HRQL was 
statistically significant and linear. Higher ACQ scores corresponded with lower 
HRQL for all instruments. Each one-point increase in ACQ6 (ACQ7) score was 
associated with the following changes: -0.064 EQ-5D (-0.069 for ACQ7), -5.985 VAS 
(-4.5 for ACQ7) and -1.05 mini-AQLQ (-1.03 for ACQ7). Different cut-points 
resulted in slightly different magnitude decrements but similar directionality for 
each HRQL instrument. CONCLUSIONS: Poor asthma control is highly correlated 
with decreased HRQL as measured by the mini-AQLQ and the EQ-5D.  
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OBJECTIVES: To examine smokers’ beliefs in potential effectiveness of available 
smoking cessation interventions in Jordan. METHODS: A cross-sectional survey-
based study in a convenient sample of willing adults in Amman, Jordan (n=600). 
Participants who reported using a cigarette or a waterpipe to smoke tobacco in 
the past 30 days were considered current smokers and included in further 
analysis. Cigarette and waterpipe smoking were being analyzed separately with 
two outcome variables for each smoking behavior: 1) believing smoking 
cessation medications are helpful in quitting versus not, and 2) believing 
educational programs/counseling by health care providers are helpful versus not. 
Multivarite logistic regression was used to determine participant characteristics 
associated with the defined outcomes. RESULTS: More smokers believed in the 
effectiveness of educational program as compared to the medications. Cigarette 
smokers who find it hard to abstain from smoking where they are not allowed to 
were more likely to believe cessation medications are helpful (OR=1.79, 
95%CI=1.01–3.15). Cigarette smokers with a lower education level (OR=0.33, 
95%CI=0.14–0.78), with a father who smokes (OR=0.39, 95%CI=0.21–0.75), or who 
tried cigar smoking in the past month (OR=0.39, 95%CI=0.18–0.86) were less likely 
to think educational programs are helpful. Waterpipe smokers who were older 
were less likely to believe cessation medications (OR=0.41, 95%CI=0.17–0.99) and 
educational programs (OR=0.38, 95%CI=0.18–0.80) are useful. Males (OR=6.07, 
95%CI=1.82–20.26) were more likely to believe cessation medications are helpful. 
Waterpipe smokers who have used cigar before (OR=0.16, 95%CI=0.05–0.51) were 
less likes to perceive the effectiveness of medication. On the other hand, whose 
father is also a waterpipe smoker (OR=0.39, 95%CI=0.17–0.89) was less likely to 
believe educational programs are helpful. CONCLUSIONS: Understanding these 
opinions from a smoker’s perspective is important in designing culturally 
appropriate interventions to help smokers quit.  
 
PRS36  
TRANSLATION AND VALIDATION PROCESS FOR THE MINNESOTA NICOTINE 
WITHDRAWAL SCALE TO THE MALAY LANGUAGE  
Blebil AQ1, Hassali MA2, Syed Sulaiman SA1, Dujaili JA1, Zin AM3 
1Universiti Sains Malaysia, Minden, Malaysia, 2Universiti Sains Malaysia, Penang, Malaysia, 
3Penang General Hospital, Jalan Residensi, Malaysia  
OBJECTIVES: To translate the Minnesota Nicotine Withdrawal Scale (MNWS) to 
Malay language and evaluate the psychometric properties of translated version. 
METHODS: A cross sectional design was used to elaborate the study data. Adult 
smokers who attend the Quit Smoking Clinic in Penang General Hospital at 
Penang State, Malaysia were included in the study. The original scale was 
translated into Malay version following the standard guidelines proposed for 
translation studies. The reliability and validity of Malay version scale was 
evaluated based on the data collected from 133 participants. Cronbach’s alpha 
coefficient was calculated to assess the reliability. In order to assess the validity 
of the scale, Factor analysis and convergent validity was employed to validate 
the psychometric properties of the scale. RESULTS: The Malay version of MNWS 
has an excellent reliability with an internal consistency was measured by total 
Cronbach’s alpha of 0.91. The test-retest reliability for the scale were presented 
an excellent reliability and stability of the translated scale with Spearman’s Rank 
Correlation Coefficient, r=0.876 (P<0.001). In addition, There was a significant 
positive correlation between carbon monoxide level, FTND total score and 
number of cigarettes smoked per day with MNWS total score (r=0.72, r=0.68 and 
r=0.68, P<0.001; respectively). A principal components analysis with orthogonal 
rotation yielded a uni-dimensional model which includes all the items of MNWS. 
CONCLUSIONS: The Malay version of MNWS is reliable and a valid measure for 
withdrawal symptoms as well as the smoking urge and it is applicable for 
clinical practice and research study.  
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OBJECTIVES: The objective of this study was to identify and compare predictors 
of smoking cessation attempts and successful smoking cessation. METHODS: A 
cross-sectional study using the 2009 U.S. Behavioral Risk Factor Surveillance 
System (BRFSS) survey database was performed. Current smokers (69,583) and 
ex-smokers who quit smoking during the previous year (8,489) were identified 
from BRFSS to compose study population. Multiple logistic regression was used 
to compare the socio-demographic characteristics and smoking-related disease 
status (1) between smokers who initiated smoking cessation attempts and those 
